DMAA
Financials
- Market Capitalization 260.98 M
- Employee N/A
- Founded 2024
- CEO N/A
- Website dmaacorp.com
- Headquarter New York, United States
- FIGI N/A
- Industry Shell Companies
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3424 |  NTWO Newbury Street II Acquisition Corp - Class A Ordinary Shares | 11.05 USD | -0.63% | -2.90% | +3.17% | +5.14% | 266.49 M USD | ||
| 3428 |  OACC Oaktree Acquisition Corp. III Life Sciences - Class A Ordinary Share | 10.74 USD | 0.00% | 0.00% | 0.00% | +1.08% | 264.02 M USD | ||
| 3460 |  SCII SC II Acquisition Corp. - Class A ordinary share | 10.13 USD | 0.00% | +0.10% | +0.20% | +2.32% | 252.22 M USD | ||
| 3473 |  MKLY McKinley Acquisition Corporation - Class A Ordinary Shares | 10.25 USD | 0.00% | +0.20% | 0.00% | +3.54% | 249.53 M USD |
Frequently asked questions about Drugs Made In America Acquisition Corp. Ordinary Shares
What is the Drugs Made In America Acquisition Corp. Ordinary Shares stock price today?
The current price of Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) is 10.75. Over the past 24 hours, the stock has changed by -0.09%. Follow the DMAA chart for real-time price dynamics.
What is the stock ticker of Drugs Made In America Acquisition Corp. Ordinary Shares?
Drugs Made In America Acquisition Corp. Ordinary Shares trades under the ticker DMAA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Drugs Made In America Acquisition Corp. Ordinary Shares stock going up?
DMAA has changed by -0.09% over the last week, +0.47% over the last month, and +2.97% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Drugs Made In America Acquisition Corp. Ordinary Shares?
Drugs Made In America Acquisition Corp. Ordinary Shares currently has a market capitalization of 260.98 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Drugs Made In America Acquisition Corp. Ordinary Shares earnings last quarter?
Last quarter, Drugs Made In America Acquisition Corp. Ordinary Shares reported earnings of 0.06 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Drugs Made In America Acquisition Corp. Ordinary Shares net income for the last quarter?
Drugs Made In America Acquisition Corp. Ordinary Shares reported net income of 1.73 M for the last quarter. The previous quarter showed 1.97 M, which means net income changed by -12.36%.
How can I buy Drugs Made In America Acquisition Corp. Ordinary Shares stock?
You can buy Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Drugs Made In America Acquisition Corp. Ordinary Shares stock?
Investing in Drugs Made In America Acquisition Corp. Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DMAA chart and related analysis on metatrader.com as part of your research.